Elsevier

Seminars in Immunology

Volume 32, August 2017, Pages 25-34
Seminars in Immunology

Review
Microbiota dysbiosis in select human cancers: Evidence of association and causality

https://doi.org/10.1016/j.smim.2017.08.001Get rights and content

Abstract

The human microbiota is a complex ecosystem of diverse microorganisms consisting of bacteria, viruses, and fungi residing predominantly in epidermal and mucosal habitats across the body, such as skin, oral cavity, lung, intestine and vagina. These symbiotic communities in health, or dysbiotic communities in disease, display tremendous interaction with the local environment and systemic responses, playing a critical role in the host’s nutrition, immunity, metabolism and diseases including cancers. While the profiling of normal microbiota in healthy populations is useful and necessary, more recent studies have focused on the microbiota associated with disease, particularly cancers. In this paper, we review current evidence on the role of the human microbiota in four cancer types (colorectal cancer, head and neck cancer, pancreatic cancer, and lung cancer) proposed as affected by both the oral and gut microbiota, and provide a perspective on current gaps in the knowledge of the microbiota and cancer.

Introduction

In 2012 there were more than 14 million new cases of human cancer, threatening 8.2 million lives worldwide, making cancer one of the leading global causes of death [1]. The global cancer burden is projected to rise as growing populations are exposed to risk factors for cancers. Data support that genetic susceptibility, environmental factors, microbial alterations and/or chronic inflammation all contribute to carcinogenesis [2]. A number of epithelial cancers are now ascribed to single microbes that modify epithelial cell biology to yield cancer development (Table 1) [2], [3], [4], [5], [6], [7]. Only recently, however, have we started to appreciate the compelling evidence indicating the role of microbial communities and organization in carcinogenesis.

The emergence of next generation sequencing technologies, including high-resolution 16S rRNA gene sequencing and metagenomic technologies, has enabled discoveries of the diversity of the microbial gene repertoire [8], [9]. Based on the key features of the microbiome including microbial diversity, relative abundance and microbial gene richness [10], [11], increasing research aims to define the bacterial composition and function associated with various cancer types across the body. Compelling evidence suggests environmental and physiological factors including diet, smoking, alcohol consumption, obesity and chronic inflammation significantly and differentially modify the microbiota within diverse anatomic sites. These same factors are often linked to carcinogenesis, fostering studies to discern links between the microbiota and cancer development. One intriguing aspect of these emerging data is the putative link between the oral and/or gut microbiota and cancer biology.

Herein, we seek to give an overview on recent data revealing the relationship between microbial alterations and four types of cancers including colorectal cancer, head and neck cancer, pancreatic cancer, and lung cancer. In each of these cancers, the oral and/or the gut microbiota have been postulated to contribute to cancer pathogenesis. The detailed mechanisms underlying microbe-host interactions in carcinogenesis, usually derived from in vivo murine models, are beyond the scope of this review but have been discussed elsewhere [2], [3], [12]. Instead, we will focus on summarizing the available human epidemiological data and discuss the next potential steps in translational research to understand the interaction between the microbiota and cancer.

Section snippets

The gut microbiota and colon-inhabiting oral microbes in colorectal cancer

Each year, 1.3 million new cases of colorectal cancer (CRC) occur, which threaten 694,000 lives equally divided among both men and women worldwide [1]. In the United States, excluding gender-specific cancers, CRC remains the second leading cause of cancer-related deaths in men and women despite a significant decline in incidence rates, particularly in people over age 50 years, due to colonoscopy screening [1], [13]. Strikingly, recent epidemiological data demonstrate altered CRC incidence

The oral microbiota and head and neck cancers

Head and neck cancers refer to the malignancies of the mucous membranes lining the head and neck cavities, including the nasal cavity and paranasal sinuses, oral cavity, pharynx (nasopharynx, oropharynx and hypopharynx), and larynx [40]. Ninety percent of head and neck cancers are squamous cell carcinomas (HNSCC) originating from squamous cells, among which oral SCC (OSCC) accounts for the most common malignant lesions [41]. Tobacco and alcohol consumption are two major risk factors for OSCC

The oral and gut microbiota in pancreatic cancer

Pancreatic ductal adenocarcinoma accounts for about 85% of pancreatic malignancy, however, the pancreas lacks an established microbiome. As one of the most aggressive and deadly cancer types, pancreatic cancer has an extremely poor prognosis with a five-year survival rate of about 5%, and with mortality increasing during the past decades in many countries worldwide [1], [66]. Conventional risk factors of pancreatic cancer include smoking, genetic susceptibility, obesity, diabetes mellitus,

The oral and lung microbiota in lung cancer

Lung cancer has been continuously ranked as the most common cancer type and the leading cause of cancer death worldwide. Smoking is a well-known risk factor for lung cancer due to its carcinogenic chemical components [89]. Emerging studies suggest that multiple additional factors, including systemic inflammatory responses [90], infections with certain microorganisms [91], [92], [93], [94], [95] and periodontal diseases [33], [96], [97] contribute to lung cancer development.

Summary

Despite having witnessed substantial advance of technologies and knowledge to begin to understand cancer as being attributable to the microbiota, we should recognize the limitations and challenges in pursuing causality of the bacterial microbiota in various cancer types as summarized in Table 4. Interestingly, identical cancer states can correlate with diverse dysbiosis and/or multiple microbial species that have carcinogenic potential. Overall, three hypotheses are proposed to delineate the

Acknowledgements

We acknowledge the support of the Bloomberg-Kimmel Cancer Immunotherapy Institute, the Johns Hopkins Department of Medicine and NIH grants NCI R01CA196845 (to C.L.S). J.C is supported by the Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health as an international student.

References (114)

  • Y. Xu et al.

    Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy

    Arch. Oral Biol.

    (2014)
  • H. Wang et al.

    Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas

    Genome Med.

    (2017)
  • D.S. Michaud et al.

    Periodontal disease and risk of all cancers among male never smokers: an updated analysis of the Health Professionals Follow-up Study

    Ann. Oncol.

    (2016)
  • D. Li et al.

    Pancreatic cancer

    Lancet

    (2004)
  • E.J. Shin et al.

    Pancreatic cancer screening

    Gastroenterol. Clin. North Am.

    (2012)
  • J. Otomo-Corgel et al.

    State of the science: chronic periodontitis and systemic health

    J. Evid. Based Dent. Pract.

    (2012)
  • P.P. Hujoel et al.

    An exploration of the periodontitis-cancer association

    Ann. Epidemiol.

    (2003)
  • C. Wang et al.

    Pathogenic microorganisms and pancreatic cancer

    Gastrointest. Tumors

    (2015)
  • P. Zhan et al.

    Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis

    Eur. J. Cancer

    (2011)
  • T.A. Winstone et al.

    Epidemic of lung cancer in patients with HIV infection

    Chest

    (2013)
  • D.S. Michaud et al.

    Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study

    Lancet Oncol.

    (2008)
  • J. Ferlay et al.

    GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012

    (2012)
  • R.F. Schwabe et al.

    The microbiome and cancer

    Nat. Rev. Cancer

    (2013)
  • R.M. Peek et al.

    Helicobacter pylori and gastrointestinal tract adenocarcinomas

    Nat. Rev. Cancer

    (2002)
  • C.L. Sears et al.

    Perspective: alpha-bugs, their microbial partners, and the link to colon cancer

    J. Infect. Dis.

    (2011)
  • H. Hjalgrim et al.

    Characteristics of Hodgkin’s lymphoma after infectious mononucleosis

    N. Engl. J. Med.

    (2003)
  • P.T. Nghiem et al.

    PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma

    N. Engl. J. Med.

    (2016)
  • M.G. Langille et al.

    Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

    Nat. Biotechnol.

    (2013)
  • The Human Microbiome Project Consortium

    Structure, function and diversity of the healthy human microbiome

    Nature

    (2012)
  • M. Arumugam et al.

    Enterotypes of the human gut microbiome

    Nature

    (2011)
  • J.L. Drewes et al.

    Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy

    Br. J. Cancer

    (2016)
  • R.L. Siegel et al.

    Colorectal cancer incidence patterns in the United States, 1974–2013

    J. Natl. Cancer Inst.

    (2017)
  • R. Fodde et al.

    APC, signal transduction and genetic instability in colorectal cancer

    Nat. Rev. Cancer

    (2001)
  • E. Thiele Orberg et al.

    The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis

    Mucosal Immunol

    (2016)
  • S. Wu et al.

    A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

    Nat. Med.

    (2009)
  • A.C. Goodwin et al.

    Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis

    Proc. Natl. Acad. Sci. U. S. A.

    (2011)
  • J.C. Arthur et al.

    Intestinal inflammation targets cancer-inducing activity of the microbiota

    Science

    (2012)
  • M.M. Huycke et al.

    Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA

    Carcinogenesis

    (2002)
  • C.M. Dejea et al.

    Microbiota organization is a distinct feature of proximal colorectal cancers

    Proc. Natl. Acad. Sci. U. S. A.

    (2014)
  • C. Dejea et al.

    Bacterial oncogenesis in the colon

    Future Microbiol.

    (2013)
  • P. Louis et al.

    The gut microbiota: bacterial metabolites and colorectal cancer

    Nat. Rev. Microbiol.

    (2014)
  • L. Hall-Stoodley et al.

    Bacterial biofilms: from the natural environment to infectious diseases

    Nat. Rev. Microbiol.

    (2004)
  • A. Swidsinski et al.

    Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease

    J. Clin. Microbiol.

    (2005)
  • J. Ahn et al.

    Human gut microbiome and risk for colorectal cancer

    J. Natl. Cancer Inst.

    (2013)
  • A.D. Kostic et al.

    Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

    Genome Res.

    (2012)
  • M. Castellarin et al.

    Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma

    Genome Res.

    (2012)
  • E. Vogtmann et al.

    Epidemiologic studies of the human microbiome and cancer

    Br. J. Cancer

    (2016)
  • K.J. Flynn et al.

    Metabolic and community synergy of oral bacteria in colorectal cancer

    mSphere

    (2016)
  • Q. Feng et al.

    Gut microbiome development along the colorectal adenoma-carcinoma sequence

    Nat. Commun.

    (2015)
  • J.P. Zackular et al.

    The human gut microbiome as a screening tool for colorectal cancer

    Cancer Prev. Res. (Phila)

    (2014)
  • Cited by (127)

    View all citing articles on Scopus
    View full text